Constellation Pharmaceuticals (CNST) PT Lowered to $17 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Do Kim lowered the price target on Constellation Pharmaceuticals (NASDAQ: CNST) to $17.00 (from $19.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
